The Burden of Skin and Subcutaneous Diseases in the United States From 1990 to 2017

Abstract

IMPORTANCE Skin and subcutaneous diseases affect the health of millions of individuals in the US. Data are needed that highlight the geographic trends and variations of skin disease burden across the country to guide health care decision-making.OBJECTIVE To characterize trends and variations in the burden of skin and subcutaneous tissue diseases across the US from 1990 to 2017. DESIGN, SETTING, AND PARTICIPANTSFor this cohort study, data were obtained from the Global Burden of Disease (GBD), a study with an online database that incorporates current and previous epidemiological studies of disease burden, and from GBD 2017, which includes more than 90 000 data sources such as systematic reviews, surveys, population-based disease registries, hospital inpatient and outpatient data, cohort studies, and autopsy data. The GBD separated skin conditions into 15 subcategories according to incidence, prevalence, adequacy of data, and standardized disease definitions. GBD 2017 also estimated the burden from melanoma of the skin and keratinocyte carcinoma. Data analysis for the present study was conducted from September 9, 2019, to March 31, 2020. MAIN OUTCOMES AND MEASURESPrimary study outcomes included age-standardized disability-adjusted life-years (DALYs), incidence, and prevalence. The data were stratified by US states with the highest and lowest age-standardized DALY rate per 100 000 people, incidence, and prevalence of each skin condition. The percentage change in DALY rates in each state was calculated from 1990 to 2017.RESULTS Overall, age-standardized DALY rates for skin and subcutaneous diseases increased from 1990 (821.6; 95% uncertainty interval [UI], 570.3-1124.9) to 2017 (884.2; 95% UI, 614.0-1207.9) in all 50 states and the District of Columbia. The degree of increase varied according to geographic location, with the largest percentage change of 0.12% (95% UI, 0.09%-0.15%) in New York and the smallest percentage change of 0.04% (95% UI, 0.02%-0.07%) in Colorado, 0.04% (95% UI, 0.01%-0.06%) in Nevada, 0.04% (95% UI, 0.02%-0.07%) in New Mexico, and 0.04% (95% UI, 0.02%-0.07%) in Utah. The age-standardized DALY rate, incidence, and prevalence of specific skin conditions differed among the states. New York had the highest age-standardized DALY rate for skin and subcutaneous disease in 2017 (1097.0 [95% UI, 764.9-1496.1]), whereas Wyoming had the lowest age-standardized DALY rate (672.9 [95% UI, 465.6-922.3]). In all 50 states and the District of Columbia, women had higher age-standardized DALY rates for overall skin and subcutaneous diseases than men (women: 971.20 [95% UI, 676.76-1334.59] vs men: 799.23 [95% UI, 559.62-1091.50]). However, men had higher DALY rates than women for malignant melanoma (men: 80.82 [95% UI, 51.68-123.18] vs women: 42.74 [95% UI, 34.05-70.66]) and keratinocyte carcinomas (men: 37.56 [95% UI, 29.35-49.52] vs women: 14.42 [95% UI, 10.01-20.66]).CONCLUSIONS AND RELEVANCE Data from the GBD suggest that the burden of skin and subcutaneous disease was large and that DALY rate trends varied a...

Mask‐induced Koebner phenomenon and its clinical phenotypes: A multicenter, real‐life study focusing on 873 dermatological consultations during COVID‐19 pandemics

“…Patients with psoriasis (12 [32.4%] had also a diagnosis of psoriatic arthritis) displayed a median PASI of 5.3 2‐14 and before mask use 40% were clinically stable (<10% PASI variation in two consecutive visits). Thirty patients underwent systemic antipsoriatic therapies (15 secukinumab, 8 ixekizumab, 7 ustekinumab, 4 adalimumab, 2 apremilast, and 1 etanercept) and 13 were previously Koebner negative (no previous KB episodes).…”

“…Masks short‐term and long‐term wearing for preventive exigencies are also changing the dermato‐epidemiology, 9,10 forcing dermatologists to integrate guidelines based on evidence 11…”

Gene Delivery to the Skin – How Far Have We Come?

“…An impaired skin barrier may pose a serious threat to health, and skin diseases significantly affect physical and psychological well-being. In fact, they belong to the most frequent diseases of humans causing a significant economic burden worldwide [ 5 ]. In principle, all types of skin diseases are candidates for gene therapy, ranging from inflammatory diseases over skin cancer to genodermatoses.…”

Vieillissement cutané

“…Ces maladies sont observées chez les séniors, non seulement à cause de la perte de l´élasticité de la peau sur les zones de tension, mais aussi à cause du vieillissement du système immunitaire qui perd de son efficacité [49]. La plupart des pathologies cutanées associées à l´âge nécessitent l'intervention du dermatologue [43,46] et la dermatologie du sujet âgé prend de plus en plus d'importance dans la pratique courante. À ce titre, la demande en dermatologie dans les unités de gériatrie ne cesse de s'accroître.…”

“…de télangiectasies 6 , un érythème plus important et une probabilité plus élevée de cancers cutanés [45]. Les effets des facteurs intrinsèques et extrinsèques s´accumulent avec le temps et chacun augmente la probabilité d'apparition de maladies cutanées, certaines étant surtout causées par des facteurs extrinsèques, notamment quand ils s'accumulent, comme les carcinomes cutanés, d´autres étant plus liées aux facteurs intrinsèques et à l'immunosénescence cutanée [46]. Chez les hommes âgés, les carcinomes épithéliaux peuvent ainsi être expliqués par l'alopécie androgénique qui expose le cuir chevelu aux rayons UV, la dépigmentation de la peau à ce niveau la rendant plus sensible à ces rayonnements à l'origine de cancers.…”